Clinical Trial Update: "Spot Sign" Selection of Intracerebral Hemorrhage to Guide Hemostatic Therapy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial updating the use of Spot Sign to guide hemostatic therapy in intracerebral hemorrhage.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Snippet

Sponsor: Dr. David Gladstone | Conditions: Stroke | Phase 2 | Status: COMPLETED